Feasibility Assessment Protocol

Feasibility assessment protocol systematically evaluates pharmaceutical development or manufacturing concept viability before major investment. Cost-benefit analysis compares development expenses against revenue projections. Technical feasibility establishes manufacturing scalability and process robustness. Market size determination assesses patient population adequacy. Regulatory pathway clarity reduces approval uncertainty.

Strategic gate reviews employ feasibility assessment determining progression decisions. Risk assessment identifies development vulnerabilities. Programmes failing feasibility assessments receive termination protecting resource allocation. Iterative refinement may improve marginal feasibility cases. Comprehensive feasibility evaluation prevents wasteful unsuccessful development.